SEC Company Response from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (RKTO) — Feb 11, 2019
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: Feb. 11, 2019 · CIK: 0001711786 · Accession: 0001615774-19-002259
AI Filing Summary & Sentiment
File numbers found in text: 333-227772
Show Raw Text
CORRESP
1
filename1.htm
February 11, 2019
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, DC 20549
Re: Hoth Therapeutics,
Inc.
Registration Statement on Form S-1 (File No. 333-227772)
Concurrence in Withdrawal Request
Ladies and Gentlemen:
Reference is made to our
letter, filed as correspondence via EDGAR on February 6, 2019, in which we, Laidlaw
& Company (UK) Ltd., as representative of the underwriters of the offering, joined Hoth
Therapeutics, Inc.’s (the “Company’s”) request for acceleration of the effective date of the above-referenced
Registration Statement. The Company is no longer requesting that such Registration Statement be declared effective at this time
and we hereby formally withdraw our request for acceleration of the effective date.
Sincerely,
Laidlaw & Company
(UK) Ltd.
By: /s/
Hugh Regan
Name:
Hugh Regan
Title:
Executive Director
-1-